Precious Metals

[bladerunner1717]

gfp,

I'm in KZIA in a big way. Got in around $4, so doing fine. Potential to be a 20X-bagger. Virtually unknown on The Street. A miniscule 7.5 million shares outstanding. A possible presentation at SNO (Society of Neuro-Oncology) in Novemeber. All the caveats apply including it being an Australian biotech.(ugh) My cancer docs like it. The trials are being run at Dana-Farber and MSK and St. Judes. Drug is a small molecule developed by Genentech. Recently got orphan drug designation. Also, fast track. If Phase II data is good, KZIA will look to get accelerated approval with priority review.

Bladerunner